Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
about
Biopersistence and brain translocation of aluminum adjuvants of vaccinesFrequently asked questions on seven rare adverse events following immunization.Vaccinia and other viruses with available vaccines show marked homology with the HIV-1 envelope glycoprotein: the prospect of using existing vaccines to stem the AIDS pandemic.A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosisCentral nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.Twenty years of universal vaccination against hepatitis B in Italy: achievements and challenges.Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002.Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.Transverse myelitis and vaccines: a multi-analysis.Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010Pediatric multiple sclerosis: current concepts and consensus definitions.Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Thyroid Autoimmunity.Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports.Epidemiology of multiple sclerosis in Europe: a review.Could autoimmunity be induced by vaccination?Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.Vaccines and multiple sclerosis: a systematic review.Vaccine hesitancy among general practitioners: evaluation and comparison of their immunisation practice for themselves, their patients and their children.Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France.HLA-DRB1 the notorious gene in the mosaic of autoimmunity.[Adverse ocular effects of vaccinations].[Hepatitis B vaccination: a review].Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?Vaccinations and autoimmune diseases.Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.Current therapeutic options in pediatric multiple sclerosis.Vaccines and multiple sclerosis.The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.Ten cases of systemic lupus erythematosus related to hepatitis B vaccine.Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA).Induction of the ‘ASIA’ syndrome in NZB/NZWF1 mice after injection of complete Freund’s adjuvant (CFA)
P2860
Q21129422-C8AF1596-5398-49E4-834D-932CCD03C8C2Q30234430-B5D1DFB1-1CE4-428E-A245-D2963743AE1BQ30406122-A68D6A7D-A87F-481E-9A0E-132FE5C8D578Q30630727-48F2A2F9-A4FA-44A6-BA58-F2B1E728D9BEQ34034063-E289C9E8-8737-4269-BF18-A9B7BBB5EBBDQ34074115-E19174FB-6CE0-4E97-B8C7-E80C32F5055BQ34148633-3C371A1D-4633-4F23-B7BE-1D6F9EA21B00Q34447836-1C341352-7858-46FA-BB13-26DC406AD1CEQ35010738-B4607276-2597-49F9-9C66-CA04F0B6D7E2Q36540764-FBF7A822-8A0B-4791-A013-E17C16E27339Q37330502-B9E180FC-23FA-4090-85E3-2D41E6453CAEQ37503234-FC0666C3-C4B0-4A6D-9D9C-4F531909236DQ37599503-D1879AD3-016F-485B-A418-7B5447FE1F74Q37641335-3181F7FB-4CD1-4F48-87F2-0A1F098C50A3Q37710109-D9C798FE-0B8C-46FA-A5DA-CBE7D14AC336Q37762550-623F6AF8-53DB-453A-9CE4-7A117F955A63Q38125512-61C19BF8-A28E-4FAB-AE98-C590D094119FQ38948785-353FC3F0-AC24-41C0-BD35-F69B9F78928DQ39136108-B76AB973-B934-48C7-8C41-422A6F85F420Q40415870-5FF2EFAC-5D3B-4EFE-9B8B-D9824B4A66D1Q40607323-275FDCBF-01BE-431C-9EA3-1E14F9BB22C9Q40631486-C336AAFF-7B88-435F-BF3C-A964A1496243Q41683102-3DF97F72-8206-4C77-9814-334FE9C69D6DQ42361533-B48D9E04-46B4-47AF-9627-5CDB38215D76Q44440836-09108F6E-FC3F-4C0B-8A2D-54DC477A0981Q45997873-5B0F70E6-467F-48F5-90A1-88B6E27428EEQ48805758-33BB9925-D2E2-41D8-99DF-E4A44496690CQ50080890-7CEE1952-B38B-47D7-909C-55244CF69E9AQ50177933-458BFD3B-45AD-4EFC-ABF6-30CF7D88CE40Q51369030-AB90A5C5-E06A-4195-93BB-7BC2408E9B8DQ51605952-2C0135E8-6879-4257-BACD-A13E29D69400Q55058719-84CB0AC2-0625-4A41-9D2D-3FA3E28468B7Q58004256-78D0644B-1511-4142-81A0-BE07861D88E1
P2860
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@ast
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@en
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@nl
type
label
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@ast
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@en
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@nl
prefLabel
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@ast
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@en
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@nl
P2093
P1433
P1476
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
@en
P2093
Guillaume Caridade
Marc Tardieu
Samy Suissa
Yann Mikaeloff
P304
P356
10.1212/01.WNL.0000335762.42177.07
P407
P577
2008-10-08T00:00:00Z